Jci Insight

雜志介紹

Jci Insight雜志介紹

《Jci Insight》是一本以English為主的未開放獲取國際優秀期刊，中文名稱Jci洞察力，本刊主要出版、報道醫學-MEDICINE, RESEARCH & EXPERIMENTAL領域的研究動態以及在該領域取得的各方面的經驗和科研成果，介紹該領域有關本專業的最新進展，探討行業發展的思路和方法，以促進學術信息交流，提高行業發展。該刊已被國際權威數據庫SCIE收錄，為該領域相關學科的發展起到了良好的推動作用，也得到了本專業人員的廣泛認可。該刊最新影響因子為6.3，最新CiteScore 指數為13.7。

本刊近期中國學者發表的論文主要有：

• Single-cell profiling reveals pathogenic role and differentiation trajectory of granzyme K+CD8+T cells in primary Sj?gren?s syndrome

  Author: Xu, Ting; Zhu, Hao-Xian; You, Xing; Ma, Jin-Fen; Li, Xin; Luo, Pan-Yue; Li, Yang; Lian, Zhe-Xiong; Gao, Cai-Yue

• Ciprofloxacin exacerbates dysfunction of smooth muscle cells in a microphysiological model of thoracic aortic aneurysm

  Author: Xiang, Bitao; Abudupataer, Mieradilijiang; Liu, Gang; Zhou, Xiaonan; Liu, Dingqian; Zhu, Shichao; Ming, Yang; Yin, Xiujie; Yan, Shiqiang; Sun, Yongxin; Lai, Hao; Wang, Chunsheng; Li, Jun; Zhu, Kai

• Insulin-like growth factor 2 mRNA-binding protein 3 promotes kidney injury by regulating beta-catenin signaling

  Author: Song, Dongyan; Shang, Jingyue; Long, Yinyi; Zhong, Menghua; Li, Li; Chen, Jiongcheng; Xiang, Yadie; Tan, Huishi; Zhu, Haili; Hong, Xue; Hou, Fan Fan; Fu, Haiyan; Liu, Youhua

• Rapamycin improves Graves' orbitopathy by suppressing CD4+cytotoxic T lymphocytes

  Author: Zhang, Meng; Chong, Kelvin K. L.; Chen, Zi-yi; Guo, Hui; Liu, Yu-feng; Kang, Yong-yong; Li, Yang-jun; Shi, Ting-ting; Lai, Kenneth K. H.; He, Ming-qian; Ye, Kai; Kahaly, George J.; Shi, Bing-yin; Wang, Yue

英文介紹

Jci Insight雜志英文介紹

Papers submitted to JCI Insight should present a focused line of investigation that provides meaningful and impactful contributions to the understanding of the biology of disease or new therapeutic opportunities. JCI Insight articles may build on existing paradigms in the field or provide hypothesis-generating findings (see editorial). Examples of studies suitable for JCI Insight include, but are not limited to, human genetics research, new mouse models of disease, in vivo studies of disease mechanisms, precision medicine, clinical and biomarker studies, and studies that provide new resources for the biomedical research community. Studies should include a relevant in vivo model system and/or a primary human cell or tissue model.